195 related articles for article (PubMed ID: 20981761)
1. Developmental pharmacology.
van den Anker JN
Dev Disabil Res Rev; 2010; 16(3):233-8. PubMed ID: 20981761
[TBL] [Abstract][Full Text] [Related]
2. Psychotropic medications and cytochrome P450 2D6: pharmacokinetic considerations in the elderly.
Shulman RW; Ozdemir V
Can J Psychiatry; 1997 Jun; 42 Suppl 1():4S-9S. PubMed ID: 9220124
[TBL] [Abstract][Full Text] [Related]
3. Optimizing pediatric dosing: a developmental pharmacologic approach.
Anderson GD; Lynn AM
Pharmacotherapy; 2009 Jun; 29(6):680-90. PubMed ID: 19476420
[TBL] [Abstract][Full Text] [Related]
4. Psychopharmacology of children and adolescents: pharmacokinetics and relationships of plasma/serum levels to response.
Geller B
Psychopharmacol Bull; 1991; 27(4):401-9. PubMed ID: 1813890
[TBL] [Abstract][Full Text] [Related]
5. Developmental pharmacokinetics.
van den Anker JN; Schwab M; Kearns GL
Handb Exp Pharmacol; 2011; 205():51-75. PubMed ID: 21882105
[TBL] [Abstract][Full Text] [Related]
6. Current applications of clinical genetic testing for psychiatric practice.
Mrazek DA
Minn Med; 2007 Jan; 90(1):42-3. PubMed ID: 17305105
[TBL] [Abstract][Full Text] [Related]
7. Relevance of pharmacokinetics to prescribing in psychiatry.
Ashton H; Harrison R
Br J Hosp Med; 1994 Jun 1-14; 51(11):573, 576-80. PubMed ID: 7952746
[TBL] [Abstract][Full Text] [Related]
8. Outliers on the dose-response curve: how to minimize this problem using therapeutic drug monitoring, an underutilized tool in psychiatry.
Preskorn SH
J Psychiatr Pract; 2010 May; 16(3):177-82. PubMed ID: 20485106
[TBL] [Abstract][Full Text] [Related]
9. Developmental perspectives in pediatric psychopharmacology.
Vitiello B; Jensen PS
Psychopharmacol Bull; 1995; 31(1):75-81. PubMed ID: 7675993
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics and development: are infants and children at increased risk for adverse outcomes?
Kearns GL
Curr Opin Pediatr; 1995 Apr; 7(2):220-33. PubMed ID: 7787940
[TBL] [Abstract][Full Text] [Related]
11. Use of psychotropic medications in children with developmental disabilities.
Calles JL
Pediatr Clin North Am; 2008 Oct; 55(5):1227-40, ix. PubMed ID: 18929062
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and therapeutic drug monitoring of psychotropic drugs in pediatrics.
Pichini S; Papaseit E; Joya X; Vall O; Farré M; Garcia-Algar O; de laTorre R
Ther Drug Monit; 2009 Jun; 31(3):283-318. PubMed ID: 19363463
[TBL] [Abstract][Full Text] [Related]
13. Cytostatic drugs in infants: a review on pharmacokinetic data in infants.
van den Berg H; van den Anker JN; Beijnen JH
Cancer Treat Rev; 2012 Feb; 38(1):3-26. PubMed ID: 21489698
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic drug monitoring. Principles and practice.
Preskorn SH; Burke MJ; Fast GA
Psychiatr Clin North Am; 1993 Sep; 16(3):611-45. PubMed ID: 8415237
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics and therapeutic strategies for dementia.
Cacabelos R
Expert Rev Mol Diagn; 2009 Sep; 9(6):567-611. PubMed ID: 19732004
[TBL] [Abstract][Full Text] [Related]
16. Pediatric pharmacokinetic data: implications for environmental risk assessment for children.
Ginsberg G; Hattis D; Miller R; Sonawane B
Pediatrics; 2004 Apr; 113(4 Suppl):973-83. PubMed ID: 15060190
[TBL] [Abstract][Full Text] [Related]
17. Principles of pharmacology.
Feucht C; Patel DR
Pediatr Clin North Am; 2011 Feb; 58(1):11-9, ix. PubMed ID: 21281845
[TBL] [Abstract][Full Text] [Related]
18. Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics.
Novak E; Allen PJ
Pediatr Nurs; 2007; 33(1):64-70. PubMed ID: 17411005
[TBL] [Abstract][Full Text] [Related]
19. Prescribing for children: issues in pediatric pharmacology.
Niederhauser VP
Nurse Pract; 1997 Mar; 22(3):16-8, 23, 26-8 passim. PubMed ID: 9078512
[TBL] [Abstract][Full Text] [Related]
20. Introduction: psychopharmacology.
Robb AS; van den Anker JN
Dev Disabil Res Rev; 2010; 16(3):231-2. PubMed ID: 20981760
[No Abstract] [Full Text] [Related]
[Next] [New Search]
